| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK
2 Axis Genetics, Babraham, Cambridge CB2 4AZ, UK
Correspondence
Nigel Dimmock
ndimmock{at}bio.warwick.ac.uk
The 
150 amino acid C-terminal tail of the gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 (HIV-1) is generally thought to be located inside the virion. However, we show here that both monoclonal IgG and polyclonal epitope-purified IgG specific for the 746ERDRD750 epitope that lies within the C-terminal tail neutralized infectious virus. IgG was mapped to the C-terminal tail by its failure to neutralize tail-deleted virus, and by sequencing of antibody-escape mutants. The fact that antibody does not cross lipid membranes, and infectious virus is by definition intact, suggested that ERDRD was exposed on the surface of the virion. This was confirmed by reacting virus and IgG, separating virus and unbound IgG by centrifugation, and showing that virus was neutralized to essentially the same extent as virus that had been in constant contact with antibody. Epitope exposure on virions was independent of temperature and therefore constitutive. Monoclonal antibodies specific to epitopes PDRPEG and IEEE, upstream of ERDRD, also bound to virions, suggesting that they too were located externally. Protease digestion destroyed the ERDRD and PDRPEG epitopes, consistent with their proposed external location. Altogether these data are consistent with part of the C-terminal tail of gp41 being exposed on the outside of the virion. Possible models of the structure of the gp41 tail, taking these observations into account, are discussed.
Present address: Department of Immunotherapeutics, GlaxoSmithKline Medicine and Research Centre, Stevenage SG1 2NY, UK.
Present address: Biovation Ltd, Babraham, UK.
This article has been cited by other articles:
|
|
 |
|
  L. Lu, Y. Zhu, J. Huang, X. Chen, H. Yang, S. Jiang, and Y.-H. Chen Surface Exposure of the HIV-1 Env Cytoplasmic Tail LLP2 Domain during the Membrane Fusion Process: INTERACTION WITH gp41 FUSION CORE J. Biol. Chem., June 13, 2008; 283(24): 16723 - 16731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Montero, N. E. van Houten, X. Wang, and J. K. Scott The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 54 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jiang and C. Aiken Maturation-Dependent Human Immunodeficiency Virus Type 1 Particle Fusion Requires a Carboxyl-Terminal Region of the gp41 Cytoplasmic Tail J. Virol., September 15, 2007; 81(18): 9999 - 10008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Heap, S. A. Reading, and N. J. Dimmock An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion J. Gen. Virol., May 1, 2005; 86(5): 1499 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kalia, S. Sarkar, P. Gupta, and R. C. Montelaro Antibody Neutralization Escape Mediated by Point Mutations in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41 J. Virol., February 15, 2005; 79(4): 2097 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cheung, L. McLain, M. J. Hollier, S. A. Reading, and N. J. Dimmock Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion J. Gen. Virol., January 1, 2005; 86(1): 131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, B. Gaschen, W. Blay, B. Foley, N. Haigwood, C. Kuiken, and B. Korber Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin Glycobiology, December 1, 2004; 14(12): 1229 - 1246. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
